Charles Johnson

Charles Johnson, Ph.D., currently serves as the Associate Director of Intellectual Property at Wave Life Sciences, focusing on establishing standard operating procedures and managing patent applications related to modified oligonucleotides. Previous positions include Associate Director of Patents at Ikena Oncology, where procedures for internally filing patent applications were created, and Chemistry Patent Agent at Deciphera Pharmaceuticals. Additional experience as a Patent Agent at Sterne, Kessler, Goldstein & Fox, and Emergent BioSolutions involved assisting in the preparation and prosecution of patent applications across various technology sectors. Educational qualifications include a Ph.D. in Chemistry and a Master's Degree in Chemistry from Saint Louis University, as well as a Bachelor's Degree in Biochemistry from Rockhurst University.